References
- Lötters F, Meerding WJ, Burdorf A. Reduced productivity after sickness absence due to musculoskeletal disorders and its relation to health outcomes. Scand J Work Environ Health. 2005;31(5):367–374.
- Weinstein J. Absent from work: nature versus nurture. Ann Intern Med. 2004;140(2):142–143.
- Bodi T, Siegler PE, Irie S, Khorsandian R, Nodine JH. Comparison of Phenyramidol and Placebo in Musculoskeletal Pain Syndromes. Curr Ther Res. 1962;4(4):135–145.
- Wainer AS. Pain Relief in Dysmenorrhea Premenstrual Tension Headache and Postpartum Pain. Clinical Medicine. 1960:2331–2334.
- Batterman RC, Mouratoff GJ, Kaufman JE. Evaluation of several non-narcotic analgesics for the symptomatic relief of musculoskeletal conditions. Curr Ther Res Clin Exp. 1962;4:81–88.
- Batterman RC, Grossman AJ, Mouratoff GJ. Analgesic effectiveness of phenyramidol hydrochloride, a new aminopyridine derivative. Am J Med Sci. 1959;238:315–319.
- Taylor SL. Use of Analexin in General Hospital Orthopedics. Am J Orthop. 1961;3:218.
- Gayral L, Puyuelo R, Barraud M, Moron P. (French). Action of Phenyramidol on the “Premenstrual Syndrome”. Therapie. 1964;19: 1013–1019.
- Köksal AS, Köklü S, Filik L, Sasmaz N, Sahin B. Phenyramidol-associated liver toxicity. Ann Pharmacother. 2003;37(9):1244–1246.
- Ergün H, Polat O, Demirkan NA, Müge Günalp M, Gürlers. The efficacy, safety, and pharmacokinetics of intramuscular and oral Phe-nyramidol in patients with low back pain in an emergency department. Turk J Med Sci. 2010;40(1):71–76. doi:10.3906/sag-0811–15.
- Childs JD, Piva SR, Fritz JM. Responsiveness of the numeric pain rating scale in patients with low back pain. Spine. 2005;30(11):1331–1334.
- Armstrong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut. 1987;28(5): 527–532.
- Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: a randomized, double-blind, placebo-controlled trial. Ann Int Med. 1995;123: 241–249.
- Diclofenac Sodium® [Tablet]. MIMS. [Online]. Source:DailyMed, United States National Library of Medicine. Available from: http://www.mims.com/Page.aspx?menuid=mng&name=Diclofenac+Sodium+Tablet&brief=true&CTRY=US. Accessed February 5, 2011.
- Tizanidine. Drugs.com. [Online]. Available from: http://www.drugs.com/pro/tizanidine.html. Accessed 13th December 2010.
- Tizanidine side effects. Drugs.com. [Online]. Available from: http://www.drugs.com/sfx/tizanidine-side-effects.html. Accessed 13th December 2010.
- Lee D. Tylenol (Acetaminophen) liver damage. Medicinenet.com. [Online]. Available from: http://www.medicinenet.com/tylenol_liver_damage/article.htm. Accessed 27th November 2010.
- Chlorzoxazone. Wikipedia. [Online]. Available from: http://en.wikipedia.org/wiki/Chlorzoxazone. Accessed 26th November 2010.
- Kivitz A, Ma C, Ahdieh H, Galer BS. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of Oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Clin Ther. 2006;28(3):352–364.
- Carter WA. Nonsteroidal Anti-Inflammatory Drugs. In: Tintinalli JE, Kelen GD, Stapczynski JS, editors. Emergency Medicine A comprehensive study guide. 6th ed. New York: McGraw-Hill; 2003.
- Chlorzoxazone Side Effects. Drugs.com. [Online]. Available from: http://www.drugs.com/sfx/chlorzoxazone-side-effects.html. Accessed 27th November 2010.
- Berry H, Hutchinson DR. A multicentre placebo-controlled study in general practice to evaluate the efficacy and safety of Tizanidine in acute low-back pain. J Int Med Res. 1988;16(2): 75–82.
- Tessaro L, Bandieri E, Costa G, et al. Use of Oxycodone controlled-release immediately after NSAIDs: a new approach to obtain good pain control. Eur Rev Med Pharmacol Sci. 2010;14(2):113–121.
- Williamson A. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005;14(7):798–804.
- Salaffi F, Stancati A, Silvestri CA, Ciapetti A, Grassi W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain. 2004;8(4):283–291.
- Childs J, Piva S, Fritz J. Responsiveness of the numeric pain rating scale in patients with low back pain. Spine. 2005;30(11):1331–1334.